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Abstract
Malaria has been eliminated from over 40 countries with an additional 39 currently planning for, or committed to,
elimination. Information on the likely impact of available interventions, and the required time, is urgently needed to help
plan resource allocation. Mathematical modelling has been used to investigate the impact of various interventions; the
strength of the conclusions is boosted when several models with differing formulation produce similar data. Here we
predict by using an individual-based stochastic simulation model of seasonal Plasmodium falciparum transmission that
transmission can be interrupted and parasite reintroductions controlled in villages of 1,000 individuals where the
entomological inoculation rate is ,7 infectious bites per person per year using chemotherapy and bed net strategies.
Above this transmission intensity bed nets and symptomatic treatment alone were not sufficient to interrupt transmission
and control the importation of malaria for at least 150 days. Our model results suggest that 1) stochastic events impact the
likelihood of successfully interrupting transmission with large variability in the times required, 2) the relative reduction in
morbidity caused by the interventions were age-group specific, changing over time, and 3) the post-intervention changes in
morbidity were larger than the corresponding impact on transmission. These results generally agree with the conclusions
from previously published models. However the model also predicted changes in parasite population structure as a result of
improved treatment of symptomatic individuals; the survival probability of introduced parasites reduced leading to an
increase in the prevalence of sub-patent infections in semi-immune individuals. This novel finding requires further
investigation in the field because, if confirmed, such a change would have a negative impact on attempts to eliminate the
disease from areas of moderate transmission.
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Introduction
Past malaria elimination campaigns have resulted in more than
40 countries becoming malaria-free [1,2], reinforcing that local
elimination is possible, particularly from marginal areas with
unstable transmission where an estimated 1 billion people live [3].
After two decades focused on malaria control [4], elimination is
back in the spotlight with 39 countries planning for, or already
committed to, elimination [5]. Malaria elimination entails the
interruption of malaria transmission to zero and then the
maintenance of this state by controlling the importation of
infections. While the WHO malaria elimination guidelines provide
valuable information on how to transition from control to
elimination, they do not address the likely impact of the suggested
interventions or the time frame required to achieve elimination in
different transmission settings [6].
Mathematical models have long been used to model disease
patterns with the main practical aim of understanding the
dynamics of transmission and impact of interventions well
enough to guide and manage control programs [7]. To this end,
numerous models have been developed and used to estimate the
impact of interventions including, but not limited to, insecticide
treated nets (ITNS) [8,9,10], artemisinin combination therapy
(ACT) [11], case management [12] and vaccines [10,13] in
specific settings, usually Africa. The potential for elimination
has also been investigated using more generic frameworks
[14,15]. In an ideal world countries would deploy an integrated
malaria control program using a combination of interventions
which target different aspects of transmission, to increase the
chances of success [16]. The financial and logistic reality is that
most regions need to select a subset of interventions and
therefore need information about the relative effects of different
combinations.
In this study we use an individual-based discrete-time stochastic
simulation model of seasonal Plasmodium falciparum transmission to
compare the impact of selected interventions in low to moderate
transmission settings. The interventions included in the study focus
on chemotherapy and reduction of human-mosquito contact
through use of untreated bed nets. In general, the results support
those from previous models, but also provide novel predictions of
long-term impacts on parasite carriage and population structure
when treatment coverage is improved.
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Materials and Methods
The model expands an existing parameterized within-host
dynamics model, which was validated using data from malaria
naı¨ve patients [17,18] to encompass a population of individuals
and parasites linked by mosquito transmission. This model is built
on the premise that the biology of the parasite and hosts, and their
interactions, is independent of geographic location. The epidemi-
ology of the disease is defined by the combination of social and
behavioural characteristics within the human population, the
mosquito population and climatic variables. These factors
influence the exposure of individuals to the parasite, resulting in
each host mounting an immune response dependent on their
exposure. A simple description of the processes incorporated into
the model, and the order of application, are outlined in Figure 1.
Parameter values are given in Table 1.
Human population dynamics and disease
The initial age distribution and death-rates in a community of
1,000 people were based on those reported for Gabon [19,20]. To
maintain a closed population, a birth is assumed whenever a death
occurred. The new individual is naı¨ve to malaria with no
protective maternal antibodies.
Within an individual host, three immune responses are
simulated: 1) a non-specific immune (NSI) response based on the
total number of rupturing parasites, 2) a non-variant immune
response specific to individual parasite clones, and 3) a PfEMP1
variant-specific antibody response. The mathematical form of
these responses, along with a sensitivity analysis, was first reported
in Paget-McNicol et al. [21], with some subsequent refinements
[17,18]. The majority of the parameters in the model were fitted
using data from patients infected with the El Limon and Santee
Cooper strains of P. falciparum [17]. The triggering and dynamics
of anti-PfEMP1 antibodies to specific PfEMP1 variants are as
previously defined [18]. The magnitude of the NSI response,
referred to here as fever (Ft,), has the mathematical form
Ft~
0,
Zt{Ttð Þ
20Tt
,
5
8><
>:
Zt~0
0vZtv101Tt
Zt§101Tt
where Zt is the number of infected RBC replicating on day t and Tt
is the fever threshold as previously defined [18]. Previous model
fitting was based on Ft values .2 corresponding to fevers .104uF
[17]. A lower value of 0.3 is used here as a threshold for when the
NSI response was sufficient to cause clinical symptoms. A
symptomatic episode is defined as one or more fever events not
separated by more than 7 days.
Parasite dynamics
The var genes (which encode PfEMP1) allocated to each parasite
clone are 1) randomly selected (with replacement) from the global
population of variants for introduced parasites, or 2) selected from
those present in the male and female gametes during recombina-
tion in the mosquito. No within gene recombination is included in
the model. The calculations for parasite switching and the
switching probabilities for each antigenically distinct var gene in
the population (pj) were as previously reported assuming a global
population of 400 antigenically distinct genes [18]. It is important
to note that the number of antigenically distinct var genes is less
than the number of unique var gene sequences due to antigenic
cross-reactivity. This point is most clearly highlighted by the
parity-dependent antibody response which interferes with binding
of parasites to the placenta, even though the PfEMP1 variants
Figure 1. Description of processes, and order of application, for the malaria transmission model.
doi:10.1371/journal.pone.0015149.g001
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thought to be responsible for the binding are structurally similar
but unique in sequence [22]. Little, if any data exists on the
number of antigenically distinct PfEMP1 variants circulating
within populations, so the value of 400 is assumed.
Introductions of new parasite types into the population are
permitted with a daily probability of 0.02 and implemented by
establishing a liver-stage infection with the new parasite in a
randomly selected host.
Asexual parasites replicate every 2 days and early stage
gametocytes are produced. The replication and implementation
of the non-variant specific immunity uses the mathematical form
previously described [18]:
Yr,j,i,tz1~Bi Yr,j,i,t|P|R,
1{Br,tð Þ
Antibodyj,i,t
 
{G1r,i,t
Br,t~0:2z
0:1
1zexp t0{tz30ð Þ=6ð Þ
 
z
0:2
1zexp tr{tz30ð Þ=6ð Þ
 
where Yr,j,i,t is the number of clone r asexual parasites expressing
PfEMP1 variant i in host j on day t, P is a conversion factor from
number of parasites per ml of blood to total number of parasites in
a host (assumed to be 56106), R is the maximum replication rate of
parasites in the absence of any immune response, Antibodyj,i,t is the
amount of anti-PfEMP1 antibody i for host j on day t, tr is the first
day of infection with parasite r and t0 is the first day of the first
infection within the host, and G1r,i,t are the number of early stage
gametocytes of parasite type r that express PfEMP1 variant i
produced on day t. It is assumed that the conversion rate of
asexual parasites to G1 gametocytes follows a log-normal
distribution with G1r,i,t*Bi Yr,j,i,t,10
N g,0:22ð Þ  and g= -1.6
when Ft=0, or -1.4 when Ft.0. These conversion rates are
higher than those reported for the conversion from asexual to
circulating mature gametocytes [23] to account for death of early
stage gametocytes due to susceptibility to the NSI response and
circulating anti-PfEMP1 antibodies [24,25].
Gametocyte dynamics are as previously described [26]. When
gametocytes from more than one parasite type are ingested by the
mosquito, a male and female are randomly selected to mate based
on the relative density of each parasite.
All asexual parasites and gametocytes are susceptible to the host
NSI response [24,27]. The number of parasites surviving an active
NSI response (Ft .0) follows a binomial distribution with survival
probability exp(2a6Ft) and a=1, 2, 1/2.75 and 1/1.5 for ring
stage asexual parasites, late stage asexual parasites, early stage
gametocytes and mature gametocytes, respectively. The scaling
factor, a, was used to alter the susceptibility of parasites based on
their life-stage. The difference in survival of late stage asexual
parasites compared to ring-stage parasites reflects experimental
data [27], while the relative gametocyte susceptibility assumes that
gametocytes, like stress-induced stages in other organisms, are
more resilient to increased temperature than asexual parasites. In
addition, it is assumed that sequestration of early stage
gametocytes in the spleen and bone marrow provides some
protection, relative to mature gametocytes, from the NSI effect.
Mosquito infection and transmission
The mosquito population consists of susceptible, infected (not
infectious) and infectious mosquitoes. Super-infection is not
permitted and mosquitoes do not recover from infection. The
baseline number of mosquitoes (mos0) in the population is specified,
as well as an amplification factor, ap, for each day of the year. The
amplification factor represents the relative number of mosquitoes
born and is used to introduce seasonality. The seasonal pattern
was selected so that ,95% of mosquito exposure occurred in 7
months of each year, a pattern similar to that reported for Sotuba,
Mali [28]. The number of new mosquitoes emerging to join
the susceptible population on day (t+12), mbt+12, is mbtz12~
ap|mos0| 1{Sð Þ
Fc|S
, where S is the probability of a mosquito
surviving one feeding cycle and Fc is the length of the feeding
cycle.
It is assumed each mosquito feeds randomly once per feeding
cycle, with the day of feeding within the cycle randomly assigned and
fixed for the life of the mosquito. Mosquito survival is determined
once per feeding cycle using a binomial distribution with probability
S. Infection of a susceptible mosquito during feeding is dependent on
at least one male and one female gametocyte being ingested in the
bloodmeal. The probability of an infectious mosquito bite generating
a new liver-stage infection in the host is fixed at 0.6 [29].
Table 1. Description of variables used in the model.
Variable/Description Data Value used
Probability of new parasite being introduced to population - 0.02/day
Probability of mosquito surviving one feeding cycle 0.58–0.70 [14,43] 0.65
Length of feeding cycle 2.7–3.7 days [14,43] 3 days
Probability of mosquito feeding on human 0.72–0.95 [14] 0.75
Size of mosquito blood meal 0.97 ml (median value) [44] 1 ml
Length of extrinsic incubation period (EIP) Temp. dependent [45] 9 days (at 28uC)
Larval development time Temp. dependent [45] 12 days (at 28uC)
Probability of infectious mosquito bite resulting in liver stage infection 0.583 [29] 0.6
Duration of liver stage infection 6 days [46] 6 days
Proportion of gametocytes that are male 0.2–0.3 [47,48] 0.25
Total number of antigenically distinct var genes in parasite population 350–1230* [49] 400
Number of var genes per parasite 59 [50] 60
Maximum parasite replication rate in the absence of any immune response (R) 8–32 [51] 16
*represents number of sequence types which may be more than antigenic types.
doi:10.1371/journal.pone.0015149.t001
Quantifying Malaria Control Strategies
PLoS ONE | www.plosone.org 3 December 2010 | Volume 5 | Issue 12 | e15149
Simulations
The model was compiled and executed using the Griffith
University Research Computing Services Sun Fire V20Z HPC
Cluster. Each simulation considered a village of 1,000 individuals
and used the same host, parasite and entomological parameter
values. Different transmission settings were achieved by altering
mos0 and each was run for 10,000 days to establish baseline
transmission and host immunity profile. The community profile on
day 10,000 was used as a common start point for simulations
incorporating malaria interventions.
Three primary interventions (improved treatment rates of
symptomatic individuals (T90), mass drug administration
(MDA), and untreated bed nets), plus combinations, were
simulated for 5,000 days, with 10–20 simulations for each
transmission/intervention combination. Model output was sum-
marised, graphed and analysed using Sigma Plot (Version 11) and
SAS for Windows (Version 5.1.2600, SAS Institute Inc). Each
intervention was assessed for its ability to interrupt malaria
transmission for at least 150 days, that is, there are no infectious
mosquitoes in the population for at least 150 days. We have
classified parasite introductions (importations) as being controlled
if they do not become established in the population by surviving
between transmission seasons.
Baseline conditions. Each symptomatic episode had a 50%
chance of receiving treatment. It is recognised that often there is a
delay between becoming symptomatic and seeking treatment. In
the baseline simulation it is assumed that 10% of the people who
seek treatment get that treatment within 24 hours of becoming
symptomatic, while 10%, 10%, 25%, 25% and 20% will receive
treatment 2, 3, 4, 5 and 6 days after becoming symptomatic,
respectively. This distribution of when treatment was received
following the onset of fever was based on a variety of data on
treatment seeking behaviour in Vietnam and Africa
[30,31,32,33,34]. In all simulations the use of anti-malarial drugs
to treat non-malarious fevers occurred randomly at a rate of 0.1%
of the population per day.
It is assumed that only one long-acting drug or drug
combination is administered, and that it is 100% effective with
no resistance. 100% of parasites are killed for the first 30 days post-
treatment, followed by a rapid decline in effectiveness so that by
day 35 any residual drug is ineffective, in line with elimination
profile of sulfadoxine-pyrimethamine.
T90 intervention. Each symptomatic episode had a 90%
chance of receiving treatment with 20%, 40%, 30%, 5%, 3%, 2%
of these people receiving treatment 1, 2, 3, 4, 5 and 6 days after
becoming symptomatic, respectively. The shortening of the time to
treatment is representative of the changes seen after provision of
health posts within communities in Vietnam [30].
Bed nets. 80% untreated bed net coverage is assumed with
each net providing protection from 80% of mosquito bites. Nets
are randomly assigned to individuals at the start of the intervention
and it is assumed that the bed nets are used every day. The
baseline treatment conditions are maintained.
The nets are untreated so only act to reduce human-mosquito
contact, having no effect on survival of mosquitoes. Hence the
impact of the intervention will be conservative compared to the
long-lasting ITNs currently being deployed. Inclusion of insecti-
cide effects is beyond the scope of the current work due to the need
to better quantify important ecological parameters such as the
killing probability, possible repellancy effects and mosquito
behavioural changes [35].
Where a feeding mosquito fails to get a blood meal due to a bed
net, the model assumes the mosquito to seek another host, up to a
maximum of three, after which it will source a blood meal from a
non-human source. The probability of survival during this process
is assumed to remain unchanged.
MDA. At the start of the intervention 100% of the population
received a curative dose of the same anti-malarial drug used to
treat symptomatic individuals. The treatment is repeated again 40
days into the intervention, after which no further actions are taken
other than the initial baseline conditions.
Sensitivity analysis for bed net and symptomatic
treatment interventions
The sensitivity of the model output to coverage levels for the bed
net intervention and treatment of symptomatic cases was assessed
by comparing the cumulative entomological inoculation rate (EIR)
and fever during the first five years following implementation. For
the bed net intervention, additional sensitivity analysis was
performed in which the assumed reduction in mosquito exposure
cause by a bed net was varied between 75 and 85%.
Results
The model was used to simulate infection and disease in low to
moderate transmission settings with EIRs between 2 and 15
infectious bites per person per year. Under baseline conditions
(prior to interventions) with an EIR of ,3 (low transmission), 12–
15% of the population had patent parasitemia at the peak of the
transmission season with ,1% of individuals having multiple
infections. The median prevalence of patent parasitemia ($100
parasites/ml) in the population varied from 1.9 to 2.6% across the
simulations, comparable to the median for children aged 4 to 8
years (2.0–2.9%). The mean number of fever episodes in the 0–3
year age group was 1.29–1.59 per person per year, varying
between simulations, being 84–90% of the actual number of
infections received (1.49–1.87 per person per year).
Baseline simulations in the moderate transmission scenario (EIR
,15) represent a community where the frequency of fever
episodes decreased with age from 3.5–3.9 per person per year in
the 0–3 year age group to 1.7–2.4 fevers per person per year in
.14 year olds. During the peak transmission season up to 35% of
the population had patent parasitemia with 8–10% infected with
$2 parasite strains. The median prevalence rate over the
simulation period was 5.3–7.9% in the entire population and
7.5–9.2% in children aged 4–8 years, varying between individual
simulations.
Three primary interventions, plus combinations, were simulated
for both baseline conditions. At the lower transmission (EIR,3) all
interventions except T90 interrupted transmission and this was
sustained until the end of the simulation (Table 2). The time to
reach the 150 day criterion varied between simulations of the same
intervention, highlighting the stochastic nature of the process
(Table 2). The T90+bed net intervention could interrupt
transmission in simulations with an initial EIR,7 (Figure 2).
However this was not always achieved within 13.7 years (5,000
days); the proportion of simulations resulting in interrupted
transmission decreased while the time to elimination tended to
increase with increasing EIR (Figure 2).
In the moderate transmission setting the triple combination of
MDA+T90+bed nets was the most successful intervention at
interrupting transmission and controlling subsequent parasite re-
introduction (Table 2). Using this intervention, interrupted
transmission was achieved in 85% of simulations 200–562 days
after the start of the intervention. The combination of MDA+T90
was almost as effective as the triple combination (80% success in
interrupting transmission) and was also able to contain new
parasite introductions. Although the T90 and bed net interven-
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tions were not able to interrupt transmission, alone or in
combination, both reduced the number of fever episodes, and to
a lesser extent, the EIR compared to baseline (Figure 3). The
relative benefits of the interventions on morbidity were found to be
age specific, such that the relative reduction in fevers was larger in
0–3 year olds compared to .14 year olds for the T90, bed net,
T90+bed net, MDA+T90 and MDA+T90+bed net interventions,
whereas the MDA and MDA+bed net interventions had a larger
relative impact in .14 year olds compared to 0–3 year olds
(Figure 3).
Output from the T90 intervention in the moderate transmission
setting was analysed further to investigate why the EIR
consistently started to increase after 2 years of the intervention,
even though morbidity continued to decline (Figure 3). This trend
was observed in all simulations of this intervention. This analysis
indicated that the T90 intervention caused a decrease in the
proportion of people aged .14 years with patent parasitemia, but
an increase in sub-patent parasite carriage relative to baseline
(Figure 4). The increase in sub-patent parasite carriage only
occurred in older age groups (Figure 4).
The sensitivity analysis indicated that the impact of the bed net
and symptomatic treatment interventions was dependent on
intervention coverage with higher coverage having larger impacts
on transmission and morbidity (Figure 5). The relationship
between changing intervention coverage and impact were not
linear, particularly for morbidity where bed nets had little impact
until coverage reached at least 50% (Figure 5). To assess the
sensitivity of the model output to variations in the assumed efficacy
of bed nets, the model was implemented with 80% coverage and
efficacy of 75% or 85%. Compared to the initially assumed 80%
efficacy, a reduction to 75% resulted in an average 7.1% increase
in EIR, and 18.9% increase in fever. This equates to 1.19
Figure 2. Times required to interrupt malaria transmission and probability under the T90+bed net intervention. Filled symbols
indicate times to interruption. Bars illustrate the proportion of simulations in which transmission was not interrupted within 5,000 days (13.7 years).
Ten simulations using identical starting conditions for each initial EIR were conducted.
doi:10.1371/journal.pone.0015149.g002
Table 2. Ability of simulated interventions to interrupt malaria transmission and control reintroductions.
Intervention Low transmission (EIR ,3) Moderate transmission (EIR ,15)
% interrupting transmission
(timea)
% where introductions
become established
% interrupting transmission
(timea)
% where introductions
become established
T90b 0 - 0 -
MDAc 100 (174–1,088) 100 40 (206–414) 100
Bedd 100 (1,235–4,458) 0 0 -
T90+Bed 100 (1,034–1,904) 0 0 -
MDA+Bed 100 (171–1,209) 0 65 (201–774) 100
MDA+T90 100 (174–337) 0 80 (205–679) 0
MDA+Bed+T90 100 (71–371) 0 85 (200–562) 0
aRange of time (days) until transmission is interrupted. Time to interruption is the first occurance of 150 days with no infectious mosquitoes.
b90% chance of symptomatic individuals receiving curative treatment; time between appearance of symptoms and treatment is decreased (compared to baseline).
c100% of population is treated with a curative dose at start of intervention and 40 days later with same drug as used for chemotherapy.
d80% of the population receive (and use) bed nets; use of a bed net reduces mosquito exposure by 80%.
doi:10.1371/journal.pone.0015149.t002
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Figure 3. Average long-term impacts of interventions on EIR and morbidity. Impacts for (A) EIR, (B) population morbidity, (C) morbidity in
0–3 year olds and (D) .14 year olds are given relative to baseline for moderate transmission simulations. Only results from simulations in which
elimination was not achieved and sustained are included, reducing the sample sizes to n = 3 and n= 5 for the MDA+bed+T90 and MDA+T90
interventions, respectively.
doi:10.1371/journal.pone.0015149.g003
Figure 4. Simulated impact of T90 intervention on parasitemia. Data are expressed as the ratio of mean number of patent ($100 parasites/ml;
dashed line) or sub-patent (,100 parasites/ml; solid line) infections to baseline in (A) 0–3 year olds and (B) .14 year olds. Values ,1 represent fewer
infections under the intervention compared to baseline, while .1 represents more infections under the intervention.
doi:10.1371/journal.pone.0015149.g004
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additional fevers per person over the first 5 years of the
intervention. Improving the efficacy from 80% to 85% reduced
EIR and fever by an average of 12.1% and 11.8%, respectively.
Discussion
We used a stochastic simulation model of P. falciparum disease
and transmission to assess the impact of three types of
interventions in villages with low to moderate transmission. This
study focused on low to moderate transmission as countries in
these regions are most likely to undertake elimination activities in
the current program. Prior to the interventions, the low
transmission scenario (EIR,3) represented a community with no
acquired clinical immunity and low multiplicity of infection. In
contrast, the community in the moderate transmission scenario
(EIR ,15) had some acquired clinical immunity, evidenced by the
decreasing frequency of fever episodes with age. The combination
of seasonal transmission and a long-acting anti-malarial drug
produced a relatively low number of fevers in the youngest age
group, compared to the number of infections. The parasite
dynamics within this community was similar to the pattern
reported for a small population in Brazil [36].
Our results for the generalized communities demonstrate that
interruption of P. falciparum transmission for at least 150 days using
currently available tools is possible in both low and moderate
transmission settings, supporting the results of previous studies
[8,16,37]. As expected, the likelihood of interrupted transmission
decreased with increasing EIR, while the time required increased.
It is important to note that the time estimates are a best case
scenario under the simulated conditions since the interventions
were assumed to be deployed and active on the nominated day of
implementation. This is in contrast to the usual field deployment
of interventions which are rolled out over an extended period. Also
it has been shown that population size impacts on the timeliness of
responses to interventions, particularly when approaching elimi-
nation [15]. Further analyses are required to investigate the impact
of population size on the time to interrupted transmission reported
here.
Although it was possible for many of the simulated interventions
to interrupt transmission, stochastic influences meant it was usually
not guaranteed. The current results were achieved in an
environment where parasite introductions were included, a point
of difference to other models of intervention impacts [37]. It has
been reported that even a small amount immigration of infected
people can impact on the ability to eliminate malaria [8]. We
found parasite introduction generated highly variable interruption
times in the low transmission setting, but that all interventions
except MDA were able to prevent parasite introductions becoming
established. In the moderate transmission setting, only combina-
tion interventions involving improved treatment of symptomatic
cases were able to successfully stop introductions becoming
established.
Although not recommended by WHO [6], MDA has been
deployed in Cambodia to demonstrate its role as a tool for malaria
elimination [38]. In the current study, all interventions using
MDA had an immediate and marked impact on morbidity and
transmission, however this impact decreased over time in
simulations where transmission was not interrupted or reintro-
duction was not prevented. This was particularly the case for
MDA used in isolation. The relative benefits on morbidity were
noted to be age-specific and this is attributable to the presence of
acquired clinical immunity in older individuals. Simulation results
from a different model show a similar rebound effect when
regularly administered mass screening and treatment interventions
cease [37]. Therefore, the short-lived benefits of MDA reinforce
that it should only be used in combination with other
interventions.
The model structure developed is such that interventions are
directly simulated, meaning that it is not necessary to make
assumptions a priori about the downstream impacts of the
intervention. Instead the model’s dynamic nature where transmis-
sion, host infectiousness and host immunity are intimately linked,
Figure 5. Sensitivity of model output to treatment coverage. Changes in (A) fever and (B) EIR are compared to baseline (50% treatment and
0% bed net coverage). Contours represent the ratio of intervention to baseline 5 years after start of intervention.
doi:10.1371/journal.pone.0015149.g005
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changing over time, allows downstream intervention impacts to
evolve during the simulation. To achieve these features the model
is more computationally complex than many other deterministic
models, and while simple models appear to replicate the major
features predicted by more complex models, at least in short-term
predictions [39], the results of this study highlight one of the
advantages of using a more detailed model; the ability to detect
unexpected or subtle changes in the infection profile within the
community. Such a change occurred under the T90 intervention
in the moderate transmission setting. This intervention caused the
EIR to initially decrease by 14%. However after two years the EIR
started to increase even though morbidity continued to decline.
This increase was consistently seen in all simulations of this
intervention suggesting an underlying pattern, rather than
stochastic variation. Further investigation revealed that in older
individuals the number of patent infections decreased compared to
baseline but the number of sub-patent infections increased. This
pattern, which does not occur in younger age groups, resulted
from the decreased likelihood of introduced parasites becoming
established in the population.
Anti-PfEMP1 antibodies provide variant-specific protection
against disease [40], and this is reflected in the components of
the within-host model. This means semi-immune hosts are more
likely to develop symptoms against antigenically different parasites
such as those newly introduced into a community. In the T90
intervention there is a high likelihood of symptomatic episodes
being treated. Because newly introduced parasites are more likely
to produce symptoms, they are also more likely to be terminated
by chemotherapy compared to existing parasites, thereby reducing
their survival probability. This bias influences the long-term
parasite population structure, in favour of existing parasites,
resulting in a decrease in the incidence of fever and subsequent
treatment, masking the ongoing transmission of parasites in semi-
immune hosts.
This observation has not been reported elsewhere since other
models of malaria do not typically contain the detail necessary to
monitor individual host responses to specific parasite genotypes, or
track parasite genotypes. The exception is McKenzie et al [16]
who introduced parasite cross-reactivity and found greater parasite
persistence in the absence of parasite cross-reactivity. Our results
in low to moderate transmission settings show a similar result in
the absence of treatment, but when treatment of symptomatic
individuals is included the higher likelihood of ‘‘new’’ parasites to
generate symptoms and thus be terminated by chemotherapy
before transmission outweighs the with-in host parasite selection
caused by host immunity.
It is common for the impact of control and elimination
programs to be monitored using data on malaria morbidity and
mortality and slide positive rates, particularly in children [6].
However our results predict that changes in morbidity over-
estimate the corresponding changes in transmission, and that the
impacts on morbidity are often age-specific. As expected, the
impacts of the simulated interventions are sensitive to intervention
coverage, although this relationship is not linear. The model
output is also likely to be sensitive to the assumed number of
feeding attempts made by a mosquito, although this parameter did
not form part of the sensitivity analysis. Under the assumed 3
feeding attempts, the sensitivity analysis revealed the model
output, particularly the prevalence of fever, is sensitive to the
assumed efficacy of the bed net intervention. Considering fever, a
bed net intervention with efficacy of 75% and 80% coverage had
the same impact as a bed net intervention with 80% efficacy and
,68% coverage. Bed net efficacy depends on a number of factors,
some of which are able to be influenced (eg education on proper
use, regular maintenance and repair) and some which are inherent
to a region (eg feeding characteristics of mosquito population),
providing a source of variability when comparing the impact of the
intervention between regions which appear to have the same
overall net coverage. In this generalized model we have only
considered the effect of untreated nets. However similar
conclusions have been reported for ITN interventions [41,42],
with ITN effectiveness being sensitive to the assumed killing and
repellancy effect of the insecticide, in addition to coverage [37].
This study quantifies the results from a new stochastic simulation
model applied to villages undergoing low to moderate transmission.
The results add further information to the public domain,
information ultimately aimed to help policy-makers and public
health officials better plan and combat malaria. The results also
highlight the potential under some interventions for a shift towards
sub-patent parasite carriage which would often not be detected in
either case data or standard malaria surveillance. This model
outcome warrants further investigation in the field because if
confirmed, this feature could impact on the success of elimination
efforts even in regions of low to moderate transmission.
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